نتائج البحث 201-210 من 23756 لعملية البحث عن Treatment
A Study Of Clonal Hematopoiesis (CH) And Hematological Toxicity After Cancer Treatment. Scottsdale/Phoenix, Ariz., Jacksonville, Fla., Rochester, Minn. The ...
... treatment. A virus, called VSV-hIFNbeta-NIS, which has been changed in a certain way, may be able to kill cancer cells without damaging normal cells ...
Scottsdale/Phoenix, Ariz. The purpose of this study is to evaluate a fenretinide phospholipid suspension for the treatment of T-cell non-Hodgkin's lymphoma (NHL) ...
... treatment in patients with recurrent grade 2 or 3 meningioma as measured by 6-month PFS rate. Mayo Clinic Cancer Center Neuro-Oncology Program Registry And ...
The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as measured by 6-month PFS rate, ...
Pituitary tumor registry. Rochester, Minn. The purpose of this data registry involves the collection of standard of care clinical treatment regimens, diagnostic ...
... treatment) in Breast Cancer 1/2 genes (BRCA 1/2) and PALB2 associated HER2 ... treatment, post-treatment and (when available) post-mortem soft tissue ...
Treatment is precisely tailored to your type of TNBC tumor. Mayo is able to identify tumor-infiltrating lymphocytes (TILs). These are immune cells found in and ...
Treatment Resistant Depression Subcallosal Cingulate Network. Rochester, Minn. The purpose of this study is to evaluate the effectiveness and safety of ...
Patients may receive a single dose to a liver lobe or segmental treatment delivered as a sequence of treatments approximately 30-90 days apart. The ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.